GDRX · Nasdaq · Healthcare · Health Information Services
$3.56+1.0%Nov 13 close
Next earnings: November 17, 2026
Figures through June 30, 2026, from the 10-Q filed August 5, 2026
Company outlook: revenue of $790M to $805M for Fiscal year 2026 — up 0.1% on a year earlier
GoodRx Holdings, Inc. is scheduled to report next on November 17, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
GoodRx Holdings, Inc.’s own guidance, from its results release of August 5, 2026. It is the company’s statement of what it expects, not a forecast of ours.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $200.4M | $203.1M | -1.31% |
| Profit | $8.5M | $12.8M | -33.54% |
| Profit per share | $0.02 | $0.04 | -50.00% |
| Free Cash Flow | $80.5M | $49.2M | +63.59% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We entered 2026 focused on scaling Pharma Direct and subscriptions, and the second quarter provided clear evidence that those investments are translating into stronger performance,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
GoodRx is the leading platform for medication savings in the U.S., used by nearly 25 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, pharmacy benefit managers, pharmaceutical manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $100 billion on the cost of their medications. GoodRx periodically posts information that may be important to investors on its investor relations website at https:// investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release. Investor
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from GoodRx Holdings, Inc.’s Item 2.02 8-K filed August 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
GoodRx Holdings, Inc. has no earnings call transcript available.